GLP-1 receptor agonists have known satiety-promoting effects due to central action of the neuropeptide GLP-1 [1], with reduced activation of appetite- and reward-related brain areas in response to food [18]
Since starting GLP-1 medication, Ive been tracking my BMR with a RENPHO Smart Scale
Bsicamente el objetivo es recomendar una actividad que tenga una demanda de energa suficientemente elevada como para que el metabolismo estimule la movilizacin de los cidos grasos del tejido adiposo y as poderlos emplear como fuente de energa
When you choose Eternal Peptides, expect superior results
It's not yet clear how fibers achieve this, but the authors of the review suspect that they increase the release of gut hormones, like GLP-1, thereby stimulating insulin and suppressing appetite
Noom's approach acknowledges that medication alone addresses appetite but not eating patterns or psychological drivers